Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Proc Natl Acad Sci U S A ; 119(3)2022 01 18.
Article in English | MEDLINE | ID: mdl-35017296

ABSTRACT

The 2'-5'-oligoadenylate synthetases (OAS) are innate immune sensors of cytosolic double-stranded RNA (dsRNA) that play a critical role in limiting viral infection. How these proteins are able to avoid aberrant activation by cellular RNAs is not fully understood, but adenosine-to-inosine (A-to-I) editing has been proposed to limit accumulation of endogenous RNAs that might otherwise cause stimulation of the OAS/RNase L pathway. Here, we aim to uncover whether and how such sequence modifications can restrict the ability of short, defined dsRNAs to activate the single-domain form of OAS, OAS1. Unexpectedly, we find that all tested inosine-containing dsRNAs have an increased capacity to activate OAS1, whether in a destabilizing (I•U) or standard Watson-Crick-like base pairing (I-C) context. Additional variants with strongly destabilizing A•C mismatches or stabilizing G-C pairs also exhibit increased capacity to activate OAS1, eliminating helical stability as a factor in the relative ability of the dsRNAs to activate OAS1. Using thermal difference spectra and molecular dynamics simulations, we identify both increased helical dynamics and specific local changes in helical structure as important factors in the capacity of short dsRNAs to activate OAS1. These helical features may facilitate more ready adoption of the distorted OAS1-bound conformation or stabilize important structures to predispose the dsRNA for optimal binding and activation of OAS1. These studies thus reveal the molecular basis for the greater capacity of some short dsRNAs to activate OAS1 in a sequence-independent manner.


Subject(s)
2',5'-Oligoadenylate Synthetase/chemistry , 2',5'-Oligoadenylate Synthetase/metabolism , Base Pair Mismatch , RNA, Double-Stranded/metabolism , Base Sequence , Endoribonucleases/metabolism , Enzyme Activation , Humans , Inosine/metabolism , Molecular Dynamics Simulation , Protein Structure, Secondary , RNA Editing , RNA Stability , Structure-Activity Relationship , Temperature
2.
PLoS Genet ; 13(5): e1006822, 2017 May.
Article in English | MEDLINE | ID: mdl-28562608

ABSTRACT

[This corrects the article DOI: 10.1371/journal.pgen.1006621.].

3.
PLoS Genet ; 13(2): e1006621, 2017 02.
Article in English | MEDLINE | ID: mdl-28222093

ABSTRACT

Disruption of synapses underlies a plethora of neurodevelopmental and neurodegenerative disease. Presynaptic specialization called the active zone plays a critical role in the communication with postsynaptic neuron. While the role of many proteins at the active zones in synaptic communication is relatively well studied, very little is known about how these proteins are transported to the synapses. For example, are there distinct mechanisms for the transport of active zone components or are they all transported in the same transport vesicle? Is active zone protein transport regulated? In this report we show that overexpression of Par-1/MARK kinase, a protein whose misregulation has been implicated in Autism spectrum disorders (ASDs) and neurodegenerative disorders, lead to a specific block in the transport of an active zone protein component- Bruchpilot at Drosophila neuromuscular junctions. Consistent with a block in axonal transport, we find a decrease in number of active zones and reduced neurotransmission in flies overexpressing Par-1 kinase. Interestingly, we find that Par-1 acts independently of Tau-one of the most well studied substrates of Par-1, revealing a presynaptic function for Par-1 that is independent of Tau. Thus, our study strongly suggests that there are distinct mechanisms that transport components of active zones and that they are tightly regulated.


Subject(s)
Autism Spectrum Disorder/genetics , Drosophila Proteins/genetics , Glycogen Synthase Kinase 3/genetics , Neuromuscular Junction/genetics , tau Proteins/genetics , Animals , Autism Spectrum Disorder/pathology , Axons/metabolism , Drosophila , Drosophila Proteins/metabolism , Glycogen Synthase Kinase 3/metabolism , Humans , Neurons/metabolism , Neurons/pathology , Presynaptic Terminals/metabolism , Presynaptic Terminals/pathology , Protein Transport/genetics , Synapses/genetics , Synapses/pathology , Synaptic Transmission/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...